Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan

Yoshihiro Nishida, Akira Kawai, Junya Toguchida, Akira Ogose, Keisuke Ae, Toshiyuki Kunisada, Yoshihiro Matsumoto, Tomoya Matsunobu, Kunihiko Takahashi, Kazuki Nishida, Toshifumi Ozaki

Research output: Contribution to journalArticle

Abstract

Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7%, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.

Original languageEnglish
Pages (from-to)1498-1505
Number of pages8
JournalInternational Journal of Clinical Oncology
Volume24
Issue number11
DOIs
Publication statusPublished - Nov 1 2019

Fingerprint

Aggressive Fibromatosis
Fibroma
Registries
Japan
Bone and Bones
Neoplasms
Recurrence
Survival
Therapeutics
Rare Diseases
Population

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hematology
  • Oncology

Cite this

Clinical features and treatment outcome of desmoid-type fibromatosis : based on a bone and soft tissue tumor registry in Japan. / Nishida, Yoshihiro; Kawai, Akira; Toguchida, Junya; Ogose, Akira; Ae, Keisuke; Kunisada, Toshiyuki; Matsumoto, Yoshihiro; Matsunobu, Tomoya; Takahashi, Kunihiko; Nishida, Kazuki; Ozaki, Toshifumi.

In: International Journal of Clinical Oncology, Vol. 24, No. 11, 01.11.2019, p. 1498-1505.

Research output: Contribution to journalArticle

Nishida, Y, Kawai, A, Toguchida, J, Ogose, A, Ae, K, Kunisada, T, Matsumoto, Y, Matsunobu, T, Takahashi, K, Nishida, K & Ozaki, T 2019, 'Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan', International Journal of Clinical Oncology, vol. 24, no. 11, pp. 1498-1505. https://doi.org/10.1007/s10147-019-01512-z
Nishida, Yoshihiro ; Kawai, Akira ; Toguchida, Junya ; Ogose, Akira ; Ae, Keisuke ; Kunisada, Toshiyuki ; Matsumoto, Yoshihiro ; Matsunobu, Tomoya ; Takahashi, Kunihiko ; Nishida, Kazuki ; Ozaki, Toshifumi. / Clinical features and treatment outcome of desmoid-type fibromatosis : based on a bone and soft tissue tumor registry in Japan. In: International Journal of Clinical Oncology. 2019 ; Vol. 24, No. 11. pp. 1498-1505.
@article{9e2cacd49293402d90dfb487c56676ed,
title = "Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan",
abstract = "Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7{\%}, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.",
author = "Yoshihiro Nishida and Akira Kawai and Junya Toguchida and Akira Ogose and Keisuke Ae and Toshiyuki Kunisada and Yoshihiro Matsumoto and Tomoya Matsunobu and Kunihiko Takahashi and Kazuki Nishida and Toshifumi Ozaki",
year = "2019",
month = "11",
day = "1",
doi = "10.1007/s10147-019-01512-z",
language = "English",
volume = "24",
pages = "1498--1505",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "11",

}

TY - JOUR

T1 - Clinical features and treatment outcome of desmoid-type fibromatosis

T2 - based on a bone and soft tissue tumor registry in Japan

AU - Nishida, Yoshihiro

AU - Kawai, Akira

AU - Toguchida, Junya

AU - Ogose, Akira

AU - Ae, Keisuke

AU - Kunisada, Toshiyuki

AU - Matsumoto, Yoshihiro

AU - Matsunobu, Tomoya

AU - Takahashi, Kunihiko

AU - Nishida, Kazuki

AU - Ozaki, Toshifumi

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7%, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.

AB - Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7%, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.

UR - http://www.scopus.com/inward/record.url?scp=85069471460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069471460&partnerID=8YFLogxK

U2 - 10.1007/s10147-019-01512-z

DO - 10.1007/s10147-019-01512-z

M3 - Article

AN - SCOPUS:85069471460

VL - 24

SP - 1498

EP - 1505

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 11

ER -